Case Studies Archive | BioAgilytix

Maximizing Drug Tolerance While Maintaining Sensitivity Using Novel Methods

In this study, BioAgilytix had to assess the immunogenicity of the PEGlayted therapeutic with an approach that could maximize drug tolerance while maintaining high sensitivity. Read More

Use of MSD-ECL in Support of Multiplex Biomarker Study

A top-five pharmaceutical company needed several angiogenesis biomarkers analyzed to support multiple Phase I clinical oncology studies. Read More

Inflammatory Biomarker Discovery on Luminex-BioPlex

A client supplied a set of pre- and post-dosed samples sourced from a clinical trial they were conducting, and tasked BioAgilytix with evaluating the samples for possible biomarkers indicative of an inflammatory response. Read More

PK Assay for Therapeutic Antibody Quantification in Sodium Heparin Plasma

While conducting the pre-validation stage of a pharmacokinetic assay study, a sponsor asked BioAgilytix to develop a method for analyzing a specific therapeutic antibody when the results generated by another lab were not consistent with what was expected. Read More

Case Studies

Maximizing Drug Tolerance While Maintaining Sensitivity Using Novel Methods

Use of MSD-ECL in Support of Multiplex Biomarker Study

Inflammatory Biomarker Discovery on Luminex-BioPlex

PK Assay for Therapeutic Antibody Quantification in Sodium Heparin Plasma

Speak to a Scientist Today

What would you like to discuss?

With whom will we be speaking?